These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35444807)

  • 1. Severe COVID-19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals.
    Gray PE; Bartlett AW; Tangye SG
    Clin Transl Immunology; 2022; 11(4):e1365. PubMed ID: 35444807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
    Matuozzo D; Talouarn E; Marchal A; Zhang P; Manry J; Seeleuthner Y; Zhang Y; Bolze A; Chaldebas M; Milisavljevic B; Gervais A; Bastard P; Asano T; Bizien L; Barzaghi F; Abolhassani H; Abou Tayoun A; Aiuti A; Alavi Darazam I; Allende LM; Alonso-Arias R; Arias AA; Aytekin G; Bergman P; Bondesan S; Bryceson YT; Bustos IG; Cabrera-Marante O; Carcel S; Carrera P; Casari G; Chaïbi K; Colobran R; Condino-Neto A; Covill LE; Delmonte OM; El Zein L; Flores C; Gregersen PK; Gut M; Haerynck F; Halwani R; Hancerli S; Hammarström L; Hatipoğlu N; Karbuz A; Keles S; Kyheng C; Leon-Lopez R; Franco JL; Mansouri D; Martinez-Picado J; Metin Akcan O; Migeotte I; Morange PE; Morelle G; Martin-Nalda A; Novelli G; Novelli A; Ozcelik T; Palabiyik F; Pan-Hammarström Q; de Diego RP; Planas-Serra L; Pleguezuelo DE; Prando C; Pujol A; Reyes LF; Rivière JG; Rodriguez-Gallego C; Rojas J; Rovere-Querini P; Schlüter A; Shahrooei M; Sobh A; Soler-Palacin P; Tandjaoui-Lambiotte Y; Tipu I; Tresoldi C; Troya J; van de Beek D; Zatz M; Zawadzki P; Al-Muhsen SZ; Alosaimi MF; Alsohime FM; Baris-Feldman H; Butte MJ; Constantinescu SN; Cooper MA; Dalgard CL; Fellay J; Heath JR; Lau YL; Lifton RP; Maniatis T; Mogensen TH; von Bernuth H; Lermine A; Vidaud M; Boland A; Deleuze JF; Nussbaum R; Kahn-Kirby A; Mentre F; Tubiana S; Gorochov G; Tubach F; Hausfater P; ; ; ; ; ; ; ; ; ; Meyts I; Zhang SY; Puel A; Notarangelo LD; Boisson-Dupuis S; Su HC; Boisson B; Jouanguy E; Casanova JL; Zhang Q; Abel L; Cobat A
    Genome Med; 2023 Apr; 15(1):22. PubMed ID: 37020259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human genetics of SARS-CoV-2 infection and critical COVID-19.
    Mogensen TH
    Clin Microbiol Infect; 2022 Nov; 28(11):1417-1421. PubMed ID: 35218979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
    Meisel C; Akbil B; Meyer T; Lankes E; Corman VM; Staudacher O; Unterwalder N; Kölsch U; Drosten C; Mall MA; Kallinich T; Schnabel D; Goffinet C; von Bernuth H
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19.
    Abolhassani H; Delavari S; Landegren N; Shokri S; Bastard P; Du L; Zuo F; Hajebi R; Abolnezhadian F; Iranparast S; Modaresi M; Vosughimotlagh A; Salami F; Aranda-Guillén M; Cobat A; Marcotte H; Zhang SY; Zhang Q; Rezaei N; Casanova JL; Kämpe O; Hammarström L; Pan-Hammarström Q
    J Allergy Clin Immunol; 2022 Nov; 150(5):1059-1073. PubMed ID: 36113674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω.
    Pierangeli A; Gentile M; Oliveto G; Frasca F; Sorrentino L; Matera L; Nenna R; Viscido A; Fracella M; Petrarca L; D'Ettorre G; Ceccarelli G; Midulla F; Antonelli G; Scagnolari C
    Front Immunol; 2022; 13():873232. PubMed ID: 35903094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insufficient type I IFN immunity underlies life-threatening COVID-19 pneumonia.
    Bastard P; Zhang Q; Cobat A; Jouanguy E; Zhang SY; Abel L; Casanova JL
    C R Biol; 2021 Jun; 344(1):19-25. PubMed ID: 34213846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.
    Marcus N; Frizinsky S; Hagin D; Ovadia A; Hanna S; Farkash M; Maoz-Segal R; Agmon-Levin N; Broides A; Nahum A; Rosenberg E; Kuperman AA; Dinur-Schejter Y; Berkun Y; Toker O; Goldberg S; Confino-Cohen R; Scheuerman O; Badarneh B; Epstein-Rigbi N; Etzioni A; Dalal I; Somech R
    Front Immunol; 2020; 11():614086. PubMed ID: 33519822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia.
    de Prost N; Bastard P; Arrestier R; Fourati S; Mahévas M; Burrel S; Dorgham K; Gorochov G; Tandjaoui-Lambiotte Y; Azzaoui I; Fernandes I; Combes A; Casanova JL; Mekontso-Dessap A; Luyt CE
    J Clin Immunol; 2021 Apr; 41(3):536-544. PubMed ID: 33616813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs.
    Casanova JL; Anderson MS
    J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36719370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review.
    Liu BM; Hill HR
    J Interferon Cytokine Res; 2020 Dec; 40(12):549-554. PubMed ID: 33337932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
    Asano T; Boisson B; Onodi F; Matuozzo D; Moncada-Velez M; Maglorius Renkilaraj MRL; Zhang P; Meertens L; Bolze A; Materna M; Korniotis S; Gervais A; Talouarn E; Bigio B; Seeleuthner Y; Bilguvar K; Zhang Y; Neehus AL; Ogishi M; Pelham SJ; Le Voyer T; Rosain J; Philippot Q; Soler-Palacín P; Colobran R; Martin-Nalda A; Rivière JG; Tandjaoui-Lambiotte Y; Chaïbi K; Shahrooei M; Darazam IA; Olyaei NA; Mansouri D; Hatipoğlu N; Palabiyik F; Ozcelik T; Novelli G; Novelli A; Casari G; Aiuti A; Carrera P; Bondesan S; Barzaghi F; Rovere-Querini P; Tresoldi C; Franco JL; Rojas J; Reyes LF; Bustos IG; Arias AA; Morelle G; Christèle K; Troya J; Planas-Serra L; Schlüter A; Gut M; Pujol A; Allende LM; Rodriguez-Gallego C; Flores C; Cabrera-Marante O; Pleguezuelo DE; de Diego RP; Keles S; Aytekin G; Akcan OM; Bryceson YT; Bergman P; Brodin P; Smole D; Smith CIE; Norlin AC; Campbell TM; Covill LE; Hammarström L; Pan-Hammarström Q; Abolhassani H; Mane S; Marr N; Ata M; Al Ali F; Khan T; Spaan AN; Dalgard CL; Bonfanti P; Biondi A; Tubiana S; Burdet C; Nussbaum R; Kahn-Kirby A; Snow AL; ; ; ; ; ; ; ; ; ; Bustamante J; Puel A; Boisson-Dupuis S; Zhang SY; Béziat V; Lifton RP; Bastard P; Notarangelo LD; Abel L; Su HC; Jouanguy E; Amara A; Soumelis V; Cobat A; Zhang Q; Casanova JL
    Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34413140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome.
    Abolhassani H; Landegren N; Bastard P; Materna M; Modaresi M; Du L; Aranda-Guillén M; Sardh F; Zuo F; Zhang P; Marcotte H; Marr N; Khan T; Ata M; Al-Ali F; Pescarmona R; Belot A; Béziat V; Zhang Q; Casanova JL; Kämpe O; Zhang SY; Hammarström L; Pan-Hammarström Q
    J Clin Immunol; 2022 Apr; 42(3):471-483. PubMed ID: 35091979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
    Troya J; Bastard P; Planas-Serra L; Ryan P; Ruiz M; de Carranza M; Torres J; Martínez A; Abel L; Casanova JL; Pujol A
    J Clin Immunol; 2021 Jul; 41(5):914-922. PubMed ID: 33851338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19.
    van der Made CI; Netea MG; van der Veerdonk FL; Hoischen A
    Genome Med; 2022 Aug; 14(1):96. PubMed ID: 35986347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Pegylated Interferon in Patients with Chronic Liver Diseases in the Context of SARS-CoV-2 Infection.
    Akbar SM; Mahtab MA; Aguilar JC; Uddin MH; Khan MSI; Yoshida O; Penton E; Gerardo GN; Hiasa Y
    Euroasian J Hepatogastroenterol; 2021; 11(1):27-31. PubMed ID: 34316461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.
    Torres I; Albert E; Giménez E; Alcaraz MJ; Botija P; Amat P; Remigia MJ; Beltrán MJ; Rodado C; Huntley D; Olea B; Navarro D
    Clin Microbiol Infect; 2021 Nov; 27(11):1672-1677. PubMed ID: 34174397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection.
    Cervantes-Barragan L; Vanderheiden A; Royer CJ; Davis-Gardner ME; Ralfs P; Chirkova T; Anderson LJ; Grakoui A; Suthar MS
    bioRxiv; 2021 May; ():. PubMed ID: 34013278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects.
    Pham MN; Murugesan K; Banaei N; Pinsky BA; Tang M; Hoyte E; Lewis DB; Gernez Y
    J Allergy Clin Immunol; 2022 Mar; 149(3):907-911.e3. PubMed ID: 34952033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.